AlphaStreet Newsdesk powered by AlphaStreet Intelligence
AirSculpt Technologies, Inc. reported a narrower-than-expected adjusted loss for the fourth quarter of 2025, though the body contouring provider faced revenue headwinds amid challenging market conditions. The company posted an adjusted loss of $0.02 per share, coming in narrower than the expected loss of $0.03. Revenue totaled $33.4M for the quarter, down 14.6% from the $39.2M recorded in Q4 2024. Despite the top-line decline, AirSculpt Technologies managed to deliver bottom-line profit of $1.3M.
The company processed 2,604 cases during the quarter across its network of 31 facilities. The body sculpting specialist, which focuses on minimally invasive aesthetic procedures, continues to navigate a competitive landscape as consumer discretionary spending on elective cosmetic treatments remains under pressure.
Management provided guidance for the next quarter, expecting revenue to range between $38.5M and $39.5M, suggesting a sequential improvement from the current period. Wall Street analyst sentiment on the stock remains constructive, with consensus standing at 4 buy ratings, 3 hold ratings, and 0 sell recommendations.
A detailed analysis of AirSculpt Technologies, Inc.’s quarter follows shortly on AlphaStreet.
This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content.